Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Diagnostic Accuracy of Combined Perfusion Index, Internal Jugular Vein Collapsibility Index and Cardiac Index in Predicting Post-Spinal Hypotension During Elective Cesarean Section

12 de noviembre de 2026 actualizado por: Nevine Mostafa Soliman, Menoufia University

Diagnostic Accuracy of Combined Perfusion Index, Internal Jugular Vein Collapsibility Index and Cardiac Index in Predicting Post-Spinal Hypotension During Elective Cesarean Section: A Prospective Randomized Study

compare Perfusion Index with Internal Jugular Vein Collapsibility Index (IJVCI) as a predictor for post-spinal hypotension in parturient undergoing elective caesarean section.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Descripción detallada

  • Pre-anesthetic evaluation (History-Investigation - Examination) the day before surgery.
  • NPO: 8 hours for solids, 2 hours for clear fluids.
  • Pre-medication: Ranitidine 50 mg IV + Metoclopramide 10 mg IV, 30 minutes before anesthesia.
  • 18-G IV cannula in the non-dominant forearm.
  • Standard monitoring in the operating room: pulse oximetry (SpO2), NIBP, and ECG.
  • Baseline measurements (HR, SBP, DBP, MAP, SpO2, PI, CI, IJVCI) recorded in the supine position with 15 degree left lateral tilt.
  • All indicators will be measured in a single group before spinal anesthesia and comparisons will be made for the most sensitive maneuver in prediction of post spinal hypotension.
  • Cardiac Index (CI) will be measured using cardiometry before spinal anesthesia.
  • Perfusion Index (PI) is measured (Three consecutive readings are recorded at 1-minute intervals, will be repeated with another reading after delivery of baby).• The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)
  • Internal Jugular Vein Collapsibility Index will be measured by Ultrasonographic assessment and is performed by using a 6-10 MHz linear ultrasound probe. (The patient is placed supine with 15 degree left lateral tilt, The probe is positioned horizontally at the right side of the neck at the level of the middle thyroid cartilage, obtaining a transverse view of the right IJV. M-mode imaging during both spontaneous and deep breathing).
  • Anteroposterior diameters of the IJV were estimated during the respiratory cycle. The IJV collapsibility index (IJVCI) was estimated via the following equation: Maximum diameter - lowest diameter/maximum diameter) 100% .
  • The mean of three consecutive measurements is recorded for each breathing mode in quite respiratory cycle.
  • Images will be saved for offline analysis.
  • The cut-off applied is:

IJVCI < 35-38% → lower risk of post-spinal hypotension IJVCI ≥ 38-40% → higher likelihood of hypotension after spinal anesthesia in CS.

  • Spinal anesthesia with intrathecal drug regimen 10-12 mg of 0.5% hyperbaric bupivacaine plus 25 micrograms (mic) Fentanyl].
  • Co-loading with Ringer's lactate at 10ml/Kg will be administrated, along with spinal anesthesia placement .Data Collection

Baseline:

  1. Patient demographic data (age, ASA physical status, comorbidities, current medications, and BMI).
  2. Hemodynamics (Heart rate- Mean Arterial Blood Pressure - Systolic Blood Pressure -Oxygen Saturation) baseline reading before induction of spinal anesthesia.
  3. Preoperative IJVCI measurement by ultrasound imaging in supine position.
  4. Preoperative Perfusion Index reading.
  5. Preoperative Cardiac index reading.

Intraoperative:

  1. Hemodynamic parameters (SBP, DBP, MAP, HR, SpO2) are recorded: -

    • Every 1 minute for the first 10 minutes,
    • Every 3 minutes until delivery,
    • Every 5 minutes thereafter until end of surgery.
  2. Total phenylephrine dose in microgram & Total Ephedrine dose (mg) [if persistent hypotension].

  3. Total IV fluid volume (mL)

  4. Total Blood loss (mL)

  5. Total Urine output (mL)

  6. Time from spinal block to delivery (min)

  7. Total time of surgery.

  8. All adverse events (nausea, vomiting, hypotension, bradycardia, oxygen desaturation) are recorded throughout.

Definition of Outcomes All outcome definitions are pre-specified and uniformly applied across all patients: -

  • Post-spinal hypotension: A fall in systolic blood pressure (SBP) below 90 mmHg.
  • Episodes are recorded from the time of spinal injection until delivery of the baby.
  • Bradycardia: Heart rate below 50 beats per minute requiring pharmacological treatment with atropine 0.01 mg/kg IV.

Treatment of PSH

  • First-line: 200 mL Ringer's lactate rapid IV infusion.
  • If SBP remains below 90 mmHg phenylephrine 25-100 microgram if persistent hypotension gives Ephedrine 5-15 mg IV bolus.
  • Bradycardia (HR < 50 bpm): Atropine 0.01 mg/kg IV.
  • All vasopressor doses and additional fluid volumes administered are recorded.

Tipo de estudio

De observación

Inscripción (Estimado)

50

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Alexandria, Egipto
        • Reclutamiento
        • Menoufia University,Faculty of Medicine
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 40 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Método de muestreo

Muestra no probabilística

Población de estudio

Adults undergoing Elective Cesarean Section at Menoufia University Hospitals

Descripción

Inclusion Criteria:

  • Full-term pregnant women undergoing elective cesarean section under spinal anesthesia (gestational age >= 37 weeks), singleton pregnancy.

    • Age: 18-40 years.
    • ASA I, II.
    • BMI: 18.5-35 kg/m2.

Exclusion Criteria:

  • • Patient refusal or inability to provide informed consent.

    • Emergency cesarean section.
    • Known contraindications to spinal anesthesia (coagulopathy, local infection, elevated ICP).
    • Baseline hypotension (SBP < 100 mmHg) prior to spinal anesthesia.
    • Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia).
    • Placenta previa or antepartum hemorrhage.
    • Multiple pregnancy or known fetal abnormality.
    • BMI > 35 kg/m2.
    • Pre-existing cardiovascular, cerebrovascular, or significant pulmonary disease.
    • Gestational diabetes or uncontrolled systemic disease.
    • Hemoglobin < 8 g/dL or known haemoglobinopathy.
    • Peripheral vascular disease affects pulse oximetry signal quality.
    • More than two attempts at lumbar puncture or failed.
    • Inadequate spinal block.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Perfusion Index (PI) group measured by pulse oximeter
  • Perfusion Index (PI) is measured using a validated multi-parameter monitor with a pulse oximetry module (Mindray uMEC 12 or equivalent).
  • The probe is placed on the right index finger in the supine position before induction of spinal anesthesia block.
  • Three consecutive readings are recorded at 1-minute intervals.
  • These steps will be repeated with another reading after delivery of baby.
  • Then the mean value is used as the baseline PI.
  • The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)

is measured using a validated multi-parameter monitor with a pulse oximetry module (Mindray uMEC 12 or equivalent).

  • The probe is placed on the right index finger in the supine position before induction of spinal anesthesia block.
  • Three consecutive readings are recorded at 1-minute intervals.
  • These steps will be repeated with another reading after delivery of baby.
  • Then the mean value is used as the baseline PI.
  • The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)
Internal Jugular Vein Collapsibility Index group will be measured by ultrasonography
  • Internal Jugular Vein Collapsibility Index will be measured by Ultrasonographic assessment and is performed by using a 6-10 MHz linear ultrasound probe.
  • The patient is placed supine with 15 degree left lateral tilt.
  • The probe is positioned horizontally at the right side of the neck at the level of the middle thyroid cartilage, obtaining a transverse view of the right IJV. M-mode imaging during both spontaneous and deep breathing.
  • Anteroposterior diameters of the IJV were estimated during the respiratory cycle. The IJV collapsibility index (IJVCI) was estimated via the following equation: Maximum diameter - lowest diameter/maximum diameter) 100% [20].
  • The mean of three consecutive measurements is recorded for each breathing mode in quite respiratory cycle .
  • Images will be saved for offline analysis.
  • The cut-off applied is:

IJVCI < 35-38% → lower risk of post-spinal hypotension IJVCI ≥ 38-40% → higher likelihood of hypotension after

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
compare the diagnostic accuracy assessed by ROC curve analysis between Perfusion Index (PI) & Internal Jugular Vein Collapsibility Index (IJVCI) combined with Cardiac Index (CI) in predicting post-spinal hypotension in elective CS patients.
Periodo de tiempo: • Three consecutive readings are recorded at 1-minute intervals. • These steps will be repeated with another reading after delivery of baby.
• Three consecutive readings are recorded at 1-minute intervals. • These steps will be repeated with another reading after delivery of baby.

Medidas de resultado secundarias

Medida de resultado
Periodo de tiempo
measure systolic arterial blood pressure changes after spinal anesthesia.
Periodo de tiempo: immediately after spinal anesthesia
immediately after spinal anesthesia
Total ephedrine dose or phenylephrine dose /milligram.
Periodo de tiempo: throughout the operation
throughout the operation

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de diciembre de 2026

Finalización primaria (Estimado)

1 de diciembre de 2027

Finalización del estudio (Estimado)

1 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

12 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Publicado por primera vez (Actual)

19 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

19 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 9/2026 ANET 53

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .